U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

Online companies like Noom and Hims & Hers this year began selling compounded semaglutide, the active ingredient in Ozempic ...

Compounding pharmacies have increasingly been at the centre of safety concerns around the legitimacy and credibility of ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Sen. Bernie Sanders grilled the maker of Wegovy and Ozempic on why the drugs cost so much more in the U.S. than in European countries.

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

Apart from industry outcry, federal agencies have signaled some concern over reports of adverse events linked to compounded semaglutide due to patients miscalculating self-administered doses.